InvestorsHub Logo
Followers 73
Posts 6230
Boards Moderated 0
Alias Born 05/01/2011

Re: couldbebetter post# 171671

Friday, 01/11/2019 9:29:33 AM

Friday, January 11, 2019 9:29:33 AM

Post# of 427891
An unsolicited (hostile) bid is, I guess, conceivable -- I wondered about that earlier this week -- but hard to imagine, and would be extremely counterproductive for Pfizer if they really wanted to acquire AMRN.

If you want to get this thing at a somewhat discounted price you need it to be a friendly deal. You don't want to start a bidding war with an aggressive, lowball bid.

“The trick is in what one emphasizes. We either make ourselves miserable, or we make ourselves happy. The amount of work is the same.” Carlos Castaneda

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News